Details
Stereochemistry | ACHIRAL |
Molecular Formula | C37H35F2N3O4S |
Molecular Weight | 655.753 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C(=O)C1=CN(CC2=C(F)C=CC=C2F)C3=C(C(CN(C)CC4=CC=CC=C4)=C(S3)C5=CC=C(NC(=O)C6(O)CC6)C=C5)C1=O
InChI
InChIKey=NWNSIURBDQNMCZ-UHFFFAOYSA-N
InChI=1S/C37H35F2N3O4S/c1-22(2)32(43)28-21-42(20-26-29(38)10-7-11-30(26)39)35-31(33(28)44)27(19-41(3)18-23-8-5-4-6-9-23)34(47-35)24-12-14-25(15-13-24)40-36(45)37(46)16-17-37/h4-15,21-22,46H,16-20H2,1-3H3,(H,40,45)
Molecular Formula | C37H35F2N3O4S |
Molecular Weight | 655.753 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:47:35 GMT 2023
by
admin
on
Sat Dec 16 11:47:35 GMT 2023
|
Record UNII |
2GGV6T2C5B
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
253433-89-5
Created by
admin on Sat Dec 16 11:47:35 GMT 2023 , Edited by admin on Sat Dec 16 11:47:35 GMT 2023
|
PRIMARY | |||
|
9939511
Created by
admin on Sat Dec 16 11:47:35 GMT 2023 , Edited by admin on Sat Dec 16 11:47:35 GMT 2023
|
PRIMARY | |||
|
2GGV6T2C5B
Created by
admin on Sat Dec 16 11:47:35 GMT 2023 , Edited by admin on Sat Dec 16 11:47:35 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Class: Antihormone, Small molecule; Mechanism of Action: Gonadotropin releasing hormone inhibitor; Highest Development Phase: Discontinued for Endometriosis and Prostate cancer; Most Recent Events: 07 Feb 2007 Discontinued - Phase-I for Endometriosis in Japan (PO), 07 Feb 2007 Discontinued - Phase-I for Prostate cancer in Japan (PO)
|